GAROFALO HEALTH CARE SPA (GHC.MI) Fundamental Analysis & Valuation

BIT:GHC • IT0005345233

Current stock price

5.21 EUR
+0.15 (+2.96%)
Last:

This GHC.MI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

7

1. GHC.MI Profitability Analysis

1.1 Basic Checks

  • GHC had positive earnings in the past year.
  • In the past year GHC had a positive cash flow from operations.
  • GHC had positive earnings in each of the past 5 years.
  • In the past 5 years GHC always reported a positive cash flow from operatings.
GHC.MI Yearly Net Income VS EBIT VS OCF VS FCFGHC.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M

1.2 Ratios

  • GHC has a Return On Assets of 4.34%. This is amongst the best in the industry. GHC outperforms 85.19% of its industry peers.
  • With a decent Return On Equity value of 11.00%, GHC is doing good in the industry, outperforming 74.07% of the companies in the same industry.
  • GHC's Return On Invested Capital of 6.82% is amongst the best of the industry. GHC outperforms 81.48% of its industry peers.
Industry RankSector Rank
ROA 4.34%
ROE 11%
ROIC 6.82%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
GHC.MI Yearly ROA, ROE, ROICGHC.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2 4 6 8 10

1.3 Margins

  • GHC has a better Profit Margin (5.26%) than 85.19% of its industry peers.
  • GHC's Profit Margin has declined in the last couple of years.
  • Looking at the Operating Margin, with a value of 9.97%, GHC belongs to the top of the industry, outperforming 85.19% of the companies in the same industry.
  • In the last couple of years the Operating Margin of GHC has grown nicely.
  • With a Gross Margin value of 44.56%, GHC perfoms like the industry average, outperforming 55.56% of the companies in the same industry.
  • In the last couple of years the Gross Margin of GHC has remained more or less at the same level.
Industry RankSector Rank
OM 9.97%
PM (TTM) 5.26%
GM 44.57%
OM growth 3Y-4.41%
OM growth 5Y4.95%
PM growth 3Y-10.45%
PM growth 5Y-3.02%
GM growth 3Y-1.03%
GM growth 5Y-0.87%
GHC.MI Yearly Profit, Operating, Gross MarginsGHC.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. GHC.MI Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), GHC is destroying value.
  • GHC has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
GHC.MI Yearly Shares OutstandingGHC.MI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
GHC.MI Yearly Total Debt VS Total AssetsGHC.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

  • GHC has an Altman-Z score of 2.16. This is not the best score and indicates that GHC is in the grey zone with still only limited risk for bankruptcy at the moment.
  • GHC has a Altman-Z score of 2.16. This is in the better half of the industry: GHC outperforms 74.07% of its industry peers.
  • The Debt to FCF ratio of GHC is 14.60, which is on the high side as it means it would take GHC, 14.60 years of fcf income to pay off all of its debts.
  • GHC has a Debt to FCF ratio (14.60) which is comparable to the rest of the industry.
  • GHC has a Debt/Equity ratio of 0.66. This is a neutral value indicating GHC is somewhat dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.66, GHC is in the better half of the industry, outperforming 77.78% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.66
Debt/FCF 14.6
Altman-Z 2.16
ROIC/WACC0.9
WACC7.6%
GHC.MI Yearly LT Debt VS Equity VS FCFGHC.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

2.3 Liquidity

  • GHC has a Current Ratio of 1.23. This is a normal value and indicates that GHC is financially healthy and should not expect problems in meeting its short term obligations.
  • With a Current ratio value of 1.23, GHC perfoms like the industry average, outperforming 59.26% of the companies in the same industry.
  • A Quick Ratio of 1.18 indicates that GHC should not have too much problems paying its short term obligations.
  • The Quick ratio of GHC (1.18) is better than 66.67% of its industry peers.
Industry RankSector Rank
Current Ratio 1.23
Quick Ratio 1.18
GHC.MI Yearly Current Assets VS Current LiabilitesGHC.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. GHC.MI Growth Analysis

3.1 Past

  • GHC shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 19.05%, which is quite good.
  • The Earnings Per Share has been growing by 12.93% on average over the past years. This is quite good.
  • Looking at the last year, GHC shows a small growth in Revenue. The Revenue has grown by 4.04% in the last year.
  • Measured over the past years, GHC shows a quite strong growth in Revenue. The Revenue has been growing by 18.29% on average per year.
EPS 1Y (TTM)19.05%
EPS 3Y3.24%
EPS 5Y12.93%
EPS Q2Q%43.45%
Revenue 1Y (TTM)4.04%
Revenue growth 3Y15.01%
Revenue growth 5Y18.29%
Sales Q2Q%4.21%

3.2 Future

  • Based on estimates for the next years, GHC will show a small growth in Earnings Per Share. The EPS will grow by 1.10% on average per year.
  • The Revenue is expected to grow by 2.50% on average over the next years.
EPS Next Y-10%
EPS Next 2Y0%
EPS Next 3Y1.1%
EPS Next 5YN/A
Revenue Next Year4.91%
Revenue Next 2Y3.48%
Revenue Next 3Y2.92%
Revenue Next 5Y2.5%

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
GHC.MI Yearly Revenue VS EstimatesGHC.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 100M 200M 300M 400M 500M
GHC.MI Yearly EPS VS EstimatesGHC.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0.1 0.2 0.3

More info and screens

Find the best growth stocksShow best growing peers

3

4. GHC.MI Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 12.40, the valuation of GHC can be described as correct.
  • Based on the Price/Earnings ratio, GHC is valued cheaply inside the industry as 81.48% of the companies are valued more expensively.
  • GHC's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 26.91.
  • GHC is valuated rather expensively with a Price/Forward Earnings ratio of 19.11.
  • Based on the Price/Forward Earnings ratio, GHC is valued a bit more expensive than the industry average as 66.67% of the companies are valued more cheaply.
  • GHC's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 21.99.
Industry RankSector Rank
PE 12.4
Fwd PE 19.11
GHC.MI Price Earnings VS Forward Price EarningsGHC.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • GHC's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. GHC is cheaper than 77.78% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, GHC is valued a bit more expensive than 66.67% of the companies in the same industry.
Industry RankSector Rank
P/FCF 30.31
EV/EBITDA 6.46
GHC.MI Per share dataGHC.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

  • The decent profitability rating of GHC may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.96
EPS Next 2Y0%
EPS Next 3Y1.1%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

4

5. GHC.MI Dividend Analysis

5.1 Amount

  • GHC has a Yearly Dividend Yield of 1.91%.
  • GHC's Dividend Yield is a higher than the industry average which is at 1.64.
  • GHC's Dividend Yield is comparable with the S&P500 average which is at 1.82.
Industry RankSector Rank
Dividend Yield 1.91%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

  • GHC pays out 20.36% of its income as dividend. This is a sustainable payout ratio.
DP20.36%
EPS Next 2Y0%
EPS Next 3Y1.1%
GHC.MI Yearly Income VS Free CF VS DividendGHC.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M
GHC.MI Dividend Payout.GHC.MI Dividend Payout, showing the Payout Ratio.GHC.MI Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

GHC.MI Fundamentals: All Metrics, Ratios and Statistics

GAROFALO HEALTH CARE SPA

BIT:GHC (4/29/2026, 3:50:58 PM)

5.21

+0.15 (+2.96%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Industry Strength62.16
Industry Growth45.33
Earnings (Last)11-14
Earnings (Next)N/A
Inst Owners10.7%
Inst Owner ChangeN/A
Ins Owners63%
Ins Owner ChangeN/A
Market Cap469.94M
Revenue(TTM)708.47M
Net Income(TTM)37.27M
Analysts84
Price Target6.02 (15.55%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.91%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP20.36%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-10.61%
PT rev (3m)-10.61%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-15.62%
EPS NY rev (3m)-15.62%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.49%
Revenue NY rev (3m)-0.49%
Valuation
Industry RankSector Rank
PE 12.4
Fwd PE 19.11
P/S 0.66
P/FCF 30.31
P/OCF 9.58
P/B 1.39
P/tB N/A
EV/EBITDA 6.46
EPS(TTM)0.42
EY8.06%
EPS(NY)0.27
Fwd EY5.23%
FCF(TTM)0.17
FCFY3.3%
OCF(TTM)0.54
OCFY10.44%
SpS7.85
BVpS3.76
TBVpS-0.38
PEG (NY)N/A
PEG (5Y)0.96
Graham Number5.95874 (14.37%)
Profitability
Industry RankSector Rank
ROA 4.34%
ROE 11%
ROCE 9.76%
ROIC 6.82%
ROICexc 7.11%
ROICexgc 15.3%
OM 9.97%
PM (TTM) 5.26%
GM 44.57%
FCFM 2.19%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-4.41%
OM growth 5Y4.95%
PM growth 3Y-10.45%
PM growth 5Y-3.02%
GM growth 3Y-1.03%
GM growth 5Y-0.87%
F-Score8
Asset Turnover0.82
Health
Industry RankSector Rank
Debt/Equity 0.66
Debt/FCF 14.6
Debt/EBITDA 2.29
Cap/Depr 120.2%
Cap/Sales 4.73%
Interest Coverage 7.36
Cash Conversion 49.78%
Profit Quality 41.6%
Current Ratio 1.23
Quick Ratio 1.18
Altman-Z 2.16
F-Score8
WACC7.6%
ROIC/WACC0.9
Cap/Depr(3y)95.14%
Cap/Depr(5y)105.18%
Cap/Sales(3y)5.48%
Cap/Sales(5y)6.01%
Profit Quality(3y)95.32%
Profit Quality(5y)96.54%
High Growth Momentum
Growth
EPS 1Y (TTM)19.05%
EPS 3Y3.24%
EPS 5Y12.93%
EPS Q2Q%43.45%
EPS Next Y-10%
EPS Next 2Y0%
EPS Next 3Y1.1%
EPS Next 5YN/A
Revenue 1Y (TTM)4.04%
Revenue growth 3Y15.01%
Revenue growth 5Y18.29%
Sales Q2Q%4.21%
Revenue Next Year4.91%
Revenue Next 2Y3.48%
Revenue Next 3Y2.92%
Revenue Next 5Y2.5%
EBIT growth 1Y9.16%
EBIT growth 3Y9.94%
EBIT growth 5Y24.14%
EBIT Next Year68.22%
EBIT Next 3Y22.5%
EBIT Next 5Y16.89%
FCF growth 1Y15.72%
FCF growth 3Y-18.74%
FCF growth 5Y7.46%
OCF growth 1Y40.15%
OCF growth 3Y3.79%
OCF growth 5Y16.39%

GAROFALO HEALTH CARE SPA / GHC.MI Fundamental Analysis FAQ

What is the ChartMill fundamental rating of GAROFALO HEALTH CARE SPA (GHC.MI) stock?

ChartMill assigns a fundamental rating of 5 / 10 to GHC.MI.


What is the valuation status for GHC stock?

ChartMill assigns a valuation rating of 3 / 10 to GAROFALO HEALTH CARE SPA (GHC.MI). This can be considered as Overvalued.


What is the profitability of GHC stock?

GAROFALO HEALTH CARE SPA (GHC.MI) has a profitability rating of 7 / 10.


Can you provide the PE and PB ratios for GHC stock?

The Price/Earnings (PE) ratio for GAROFALO HEALTH CARE SPA (GHC.MI) is 12.4 and the Price/Book (PB) ratio is 1.39.


What is the expected EPS growth for GAROFALO HEALTH CARE SPA (GHC.MI) stock?

The Earnings per Share (EPS) of GAROFALO HEALTH CARE SPA (GHC.MI) is expected to decline by -10% in the next year.